🎉 M&A multiples are live!
Check it out!

Solesence Valuation Multiples

Discover revenue and EBITDA valuation multiples for Solesence and similar public comparables like Sarantis Group, EZZ Life Science, and Lavipharm.

Solesence Overview

About Solesence

Solesence Inc is a scientifically driven health care solutions company across beauty and life science categories, protecting skin from environmental aggressors and enhancing the aesthetic appeal of healthy products. The group is engaged in the beauty category that develops and manufactures clean, inclusive, mineral-based skincare and makeup products at the forefront of skin health. Its brands are Stress Defense, Kleair, and Bloom.


Founded

1989

HQ

United States of America
Employees

98

Website

solesence.com

Sectors

Health & Beauty

Financials

Last FY Revenue $52.3M

Last FY EBITDA $6.1M

EV

$260M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Solesence Financials

See Solesence valuation multiples based on analyst estimates

Solesence P&L

In the most recent fiscal year, Solesence reported revenue of $52.3M and EBITDA of $6.1M.

Solesence expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Solesence valuation multiples based on analyst estimates
NTM Last FY FY 2025 FY 2026 FY 2027
Revenue XXX $52.3M XXX XXX XXX
Gross Profit XXX $16.2M XXX XXX XXX
Gross Margin XXX 31% XXX XXX XXX
EBITDA XXX $6.1M XXX XXX XXX
EBITDA Margin XXX 12% XXX XXX XXX
EBIT XXX $5.1M XXX XXX XXX
EBIT Margin XXX 10% XXX XXX XXX
Net Profit XXX $4.2M XXX XXX XXX
Net Margin XXX 8% XXX XXX XXX
Net Debt XXX $3.6M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Solesence Stock Performance

Solesence has current market cap of $238M, and EV of $260M.

Market Cap Evolution

Solesence Stock Data

As of September 12, 2025, Solesence's stock price is $3.

See Solesence trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$260M $238M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Solesence Valuation Multiples

Solesence's trades at 5.0x EV/Revenue multiple, and 42.9x EV/EBITDA.

See valuation multiples for Solesence and 15K+ public comps

Solesence Financial Valuation Multiples

As of September 12, 2025, Solesence has market cap of $238M and EV of $260M.

Equity research analysts estimate Solesence's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Solesence's P/E ratio is not available.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $238M XXX $238M XXX XXX XXX
EV (current) $260M XXX $260M XXX XXX XXX
EV/Revenue n/a XXX 5.0x XXX XXX XXX
EV/EBITDA n/a XXX 42.9x XXX XXX XXX
EV/EBIT n/a XXX 50.6x XXX XXX XXX
EV/Gross Profit n/a XXX n/a XXX XXX XXX
P/E n/a XXX 56.1x XXX XXX XXX
EV/FCF n/a XXX -100.4x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Solesence Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Solesence Margins & Growth Rates

Solesence's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.

Solesence's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Solesence's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Solesence and other 15K+ public comps

Solesence Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth n/a XXX n/a XXX XXX XXX
EBITDA Margin n/a XXX 12% XXX XXX XXX
EBITDA Growth n/a XXX n/a XXX XXX XXX
Rule of 40 n/a XXX n/a XXX XXX XXX
Bessemer Rule of X XXX XXX n/a XXX XXX XXX
Revenue per Employee XXX XXX $0.5M XXX XXX XXX
Opex per Employee XXX XXX $0.1M XXX XXX XXX
S&M Expenses to Revenue XXX XXX n/a XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 7% XXX XXX XXX
Opex to Revenue XXX XXX 21% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Solesence Public Comps

See public comps and valuation multiples for Health & Beauty comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Acme United XXX XXX XXX XXX XXX XXX
EZZ Life Science XXX XXX XXX XXX XXX XXX
Lavipharm XXX XXX XXX XXX XXX XXX
Sarantis Group XXX XXX XXX XXX XXX XXX
SynBiotic XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Solesence M&A and Investment Activity

Solesence acquired  XXX companies to date.

Last acquisition by Solesence was  XXXXXXXX, XXXXX XXXXX XXXXXX . Solesence acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Solesence

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Solesence

When was Solesence founded? Solesence was founded in 1989.
Where is Solesence headquartered? Solesence is headquartered in United States of America.
How many employees does Solesence have? As of today, Solesence has 98 employees.
Who is the CEO of Solesence? Solesence's CEO is Mr. Jess A. Jankowski.
Is Solesence publicy listed? Yes, Solesence is a public company listed on NAS.
What is the stock symbol of Solesence? Solesence trades under SLSN ticker.
When did Solesence go public? Solesence went public in 1997.
Who are competitors of Solesence? Similar companies to Solesence include e.g. Acme United, EZZ Life Science, Lavipharm, Sarantis Group.
What is the current market cap of Solesence? Solesence's current market cap is $238M
Is Solesence profitable? Yes, Solesence is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.